NEW YORK – Foundation Medicine and OneOncology jointly announced on Monday a strategic partnership to use real-world clinical and genomics data to improve access to genomic profiling and personalized medicine in community oncology practices across the US.
The two entities have inked a research collaboration, which will use clinico-genomic datasets to derive molecular insights and inform patient care. “I am a big proponent of understanding the molecular landscape of a patient’s cancer in order to determine the appropriate treatment course for patients with advanced cancer over multiple lines of therapy,” Lee Schwartzberg, chief medical officer at OneOncology, said in a statement. “We’re excited to optimize comprehensive genomic profiling and its power to inform more personalized care across our network.”
Within the partnership, Nashville, Tennessee-based OneOncology, a national network of five independent, community oncology practices representing over 400 providers in the US, will use its patient data to advance research and